{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:23Z","timestamp":1791532163159,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U24CA076518"],"award-info":[{"award-number":["U24CA076518"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00011"],"award-info":[{"award-number":["75R60222C00011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-21-1-2954"],"award-info":[{"award-number":["N00014-21-1-2954"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-23-1-2057"],"award-info":[{"award-number":["N00014-23-1-2057"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.05.026","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:06:07Z","timestamp":1779300367000},"page":"1335-1345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["PTCy-Based versus ATG-Based GVHD Prophylaxis in Mismatched Unrelated Donor HCT: A Secondary Analysis of CIBMTR Data"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8355-433X","authenticated-orcid":false,"given":"Sergio","family":"Rodriguez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8589-799X","authenticated-orcid":false,"given":"Gonzalo","family":"Bentolila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2531-4017","authenticated-orcid":false,"given":"Archit","family":"Pandharipande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Gagelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-3245","authenticated-orcid":false,"given":"Nihar","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jtct.2026.05.026_bib0001","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2013-02-482547","article-title":"High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis","volume":"122","author":"F\u00fcrst","year":"2013","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.jtct.2026.05.026_bib0002","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.026_bib0003","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"issue":"25","key":"10.1016\/j.jtct.2026.05.026_bib0004","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.026_bib0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1182\/blood.2019000487","article-title":"Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation","volume":"134","author":"Battipaglia","year":"2019","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jtct.2026.05.026_bib0006","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/bloodadvances.2022007596","article-title":"Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant","volume":"6","author":"Jimenez Jimenez","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.026_bib0007","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41409-025-02678-z","article-title":"Post-transplantation cyclophosphamide and antithymocyte globulin in 8\/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT","volume":"60","author":"Moiseev","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.026_bib0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41409-019-0682-2","article-title":"Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation","volume":"55","author":"Nykolyszyn","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"28","key":"10.1016\/j.jtct.2026.05.026_bib0009","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide\u2013based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.026_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.jtct.2026.05.026_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, Multicenter Standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.026_bib0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.05.026_bib0013","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.026_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.026_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.026_bib0016","first-page":"546","article-title":"Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation","volume":"111","author":"Bordat","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.05.026_bib0017","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: A systematic review and meta-analysis","volume":"13","author":"Tang","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.026_bib0018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.jtct.2026.05.026_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247765","article-title":"Evaluating the impact of post-transplant cyclophosphamide and anti-thymocyte globulin on cmv reactivation following allogeneic hematopoietic stem cell transplantation: a systematic literature review","volume":"12","author":"Dybko","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2026.05.026_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1571678","article-title":"Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC","volume":"16","author":"Pinto","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.026_bib0021","article-title":"Bloodstream infection in allogeneic transplant patients treated with post-transplant cyclophosphamide","volume":"30","author":"Guare","year":"2024","journal-title":"Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.026_bib0022","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/bjh.70380","article-title":"Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia","volume":"208","author":"Desai","year":"2026","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.05.026_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102662","article-title":"Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis: current status and optimization strategies","volume":"97","author":"Fuji","year":"2025","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.026_bib0024","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ajh.27619","article-title":"Differential clinical and immunological impacts of anti-T-lymphocyte globulin (ATLG) vs. anti-thymocyte globulin (ATG) in preventing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: a comparative study","volume":"100","author":"Notarantonio","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.05.026_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101093","article-title":"Relapse after allogeneic transplantation with post-transplant cyclophosphamide: shattering myths and evolving insight","volume":"62","author":"McCurdy","year":"2023","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.026_bib0026","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/bloodadvances.2024014781","article-title":"PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation","volume":"9","author":"Desai","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.05.026_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.70124","article-title":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","author":"Desai","year":"2025","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.026_bib0028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ejh.14430","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation for myelodysplastic\/myeloproliferative overlap neoplasms","volume":"115","author":"Desai","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2026.05.026_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.026_bib0030","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression","volume":"129","author":"Wachsmuth","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.026_bib0031","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa2503189","article-title":"Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin","volume":"393","author":"Curtis","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:57:14Z","timestamp":1791529034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726004136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666636726004136"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.026","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTCy-Based versus ATG-Based GVHD Prophylaxis in Mismatched Unrelated Donor HCT: A Secondary Analysis of CIBMTR Data","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}